Opdivo podría mejorar los resultados de las personas que sufren un linfoma de Hodgkin
MARTES, 6 de julio de 2023 (HealthDay News) — El nivolumab (Opdivo), un medicamento de inmunoterapia muy utilizado, es más seguro y efectivo para tratar a los adultos y a los niños con un linfoma de Hodgkin que la terapia dirigida que se usa ahora co…
Learn MoreMany With Relapsed/Refractory Lymphoma in Pregnancy Delay Treatment
TUESDAY, June 6, 2023 (HealthDay News) — Most women with relapsed/refractory lymphoma during pregnancy defer therapy and there are few obstetric or neonatal complications, according to a study published online June 1 in Blood Advances.Faheem Farooq, …
Learn MoreCan Some Cancer Patients Safely Skip Radiation Therapy? New Studies Say Yes
TUESDAY, June 6, 2023 (HealthDay News) — Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One trial found that rectal cancer …
Learn MoreOpdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
TUESDAY, July 6, 2023 (HealthDay News) — The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clin…
Learn MoreWhat to Do When Tough-to-Treat Lymphoma Strikes During Pregnancy
FRIDAY, June 2, 2023 (HealthDay News) — Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.A new study may provide some perspective.Though uncommon, this issue is still…
Learn MoreEpkinly Granted Accelerated FDA Approval for Lymphoma
MONDAY, May 22, 2023 (HealthDay News) — The U.S. Food and Drug Administration has granted accelerated approval to Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from indolent lymph…
Learn MoreSmall Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
WEDNESDAY, May 10, 2023 (HealthDay News) — Crohn disease (CD) and ulcerative colitis (UC) are associated with a slightly increased risk for lymphoma, according to a study published online April 13 in Clinical Gastroenterology and Hepatology.Ola Olén …
Learn MoreCancer Risk Increased With Exposure to Four or More CT Scans by Age 18
MONDAY, April 24, 2023 (HealthDay News) — Exposure to four or more computed tomography (CT) scans before age 18 years is associated with increased risk of subsequent intracranial tumors, leukemia, and lymphoma, according to a study published online A…
Learn MoreInterferon Alfa-2b Effective for Low-Grade Lymphomatoid Granulomatosis
WEDNESDAY, April 12, 2023 (HealthDay News) — For low-grade lymphomatoid granulomatosis, interferon alfa-2b is efficacious, according to a study published online March 31 in The Lancet Haematology.Christopher Melani, M.D., from the National Institutes…
Learn MoreLos innovadores tratamientos de T con RAQ para el cáncer mejoran la calidad de vida de los pacientes
MIÉRCOLES, 5 de abril de 2023 (HealthDay News) — Una terapia que potencia al sistema inmunitario podría no solo ayudar a ciertos pacientes con cáncer a vivir más, sino también mejor, encuentra un nuevo estudio.El tratamiento, llamado terapia de célul…
Learn More